NDC 50090-4590

ENBREL

Etanercept

ENBREL is a Subcutaneous Solution in the Human Prescription Drug category. It is labeled and distributed by A-s Medication Solutions. The primary component is Etanercept.

Product ID50090-4590_3481a98e-52ad-4367-8a5d-fa3a7416ebf1
NDC50090-4590
Product TypeHuman Prescription Drug
Proprietary NameENBREL
Generic NameEtanercept
Dosage FormSolution
Route of AdministrationSUBCUTANEOUS
Marketing Start Date2019-06-07
Marketing CategoryBLA /
Application NumberBLA103795
Labeler NameA-S Medication Solutions
Substance NameETANERCEPT
Active Ingredient Strength50 mg/mL
Pharm ClassesTumor Necrosis Factor Blocker [EPC],Tumor Necrosis Factor Receptor Blocking Activity [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 50090-4590-0

1 mL in 1 KIT (50090-4590-0)
Marketing Start Date2019-10-08
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "ENBREL" or generic name "Etanercept"

NDCBrand NameGeneric Name
50090-3531ENBRELetanercept
50090-4490ENBRELetanercept
50090-4590ENBRELetanercept
58406-010ENBRELetanercept
58406-021ENBRELetanercept
58406-032ENBRELetanercept
58406-044ENBRELetanercept
58406-455ENBRELENBREL
58406-456ENBRELENBREL
58406-425ENBRELENBREL
58406-435ENBRELENBREL
58406-445ENBRELENBREL
58406-446ENBRELENBREL
58406-055ENBRELENBREL

Trademark Results [ENBREL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
ENBREL
ENBREL
75603024 not registered Dead/Abandoned
Immunex Corporation
1998-12-09
ENBREL
ENBREL
75602028 2402704 Dead/Cancelled
Immunex Corporation
1998-12-09
ENBREL
ENBREL
75602027 not registered Dead/Abandoned
Immunex Corporation
1998-12-09
ENBREL
ENBREL
75183260 2220795 Live/Registered
IMMUNEX CORPORATION
1996-10-17

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.